Richard Campion, Head of SMB at Visa Europe. Credit: Visa Richard Campion, Head of SMB at Visa Europe, explains how banks and fintechs can identify hidden small businesses and build deeper banking ...
Pharmacy industry stakeholders are currently navigating a three-year transition period to implement the 12-digit National Drug Code (NDC-12) standard. Liberty Dewey of Cardinal Health recently ...
Shares of Generate Biomedicines (GENB), an AI-driven drug discovery company, advanced about 12% today. Shares traded at $19.81 in mid-afternoon trading, a gain of $2.09 on the session. The rally ...
Shares of Generate Biomedicines Inc. NASDAQ: GENB rose 12.3% on Tuesday ahead of its initial significant post-IPO supply challenge. The biotech company was trading at $19.90 as of 12:36 EDT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results